Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Clariane Company

CLARI.PA
FR0010386334
A0LE05

Price

1.61
Today +/-
+0.04
Today %
+2.77 %
P

Clariane stock price

%
Weekly
Details

Price

Overview

The Quote Chart provides detailed and dynamic insights into the Clariane stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Clariane stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Clariane stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Clariane's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Clariane Stock Price History

DateClariane Price
10/18/20241.61 undefined
10/17/20241.57 undefined
10/16/20241.65 undefined
10/15/20241.62 undefined
10/14/20241.58 undefined
10/11/20241.59 undefined
10/10/20241.64 undefined
10/9/20241.69 undefined
10/8/20241.68 undefined
10/7/20241.69 undefined
10/4/20241.66 undefined
10/3/20241.66 undefined
10/2/20241.65 undefined
10/1/20241.69 undefined
9/30/20241.72 undefined
9/27/20241.78 undefined
9/26/20241.75 undefined
9/25/20241.72 undefined
9/24/20241.73 undefined
9/23/20241.71 undefined

Clariane Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Clariane, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Clariane from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Clariane’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Clariane. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Clariane’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Clariane’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Clariane’s growth potential.

Clariane Revenue, EBIT and net profit per share

DateClariane RevenueClariane EBITClariane Net Income
2027e6.33 B undefined427.6 M undefined0 undefined
2026e5.96 B undefined437.75 M undefined54.67 M undefined
2025e5.69 B undefined374.92 M undefined-14.66 M undefined
2024e5.44 B undefined273.98 M undefined-95.85 M undefined
20235 B undefined315.42 M undefined-105.25 M undefined
20224.44 B undefined334.4 M undefined22.1 M undefined
20214.14 B undefined383.5 M undefined91.1 M undefined
20203.77 B undefined286.1 M undefined39.4 M undefined
20193.61 B undefined358.5 M undefined114.7 M undefined
20183.33 B undefined307.7 M undefined123.1 M undefined
20173.13 B undefined286.7 M undefined163.3 M undefined
20162.98 B undefined242.4 M undefined131.3 M undefined
20152.57 B undefined185.6 M undefined58.7 M undefined
20142.22 B undefined188.3 M undefined61.3 M undefined
20131.36 B undefined102.1 M undefined28.6 M undefined
20121.11 B undefined80.5 M undefined23.3 M undefined
20111.02 B undefined80.3 M undefined21.7 M undefined
2010922.9 M undefined69 M undefined24.7 M undefined
2009850.6 M undefined56.8 M undefined15 M undefined
2008781.3 M undefined58.2 M undefined18 M undefined
2007608.4 M undefined58.8 M undefined23.1 M undefined
2006515.9 M undefined49.1 M undefined19.7 M undefined
2005283.2 M undefined29.5 M undefined29.5 M undefined
2004160.4 M undefined22.3 M undefined6.4 M undefined

Clariane Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e2027e
0.160.280.520.610.780.850.921.021.111.362.222.572.983.133.333.613.774.144.4455.445.695.966.33
-76.8881.9818.0628.458.838.4710.099.1622.3863.8615.8015.865.006.498.374.439.687.2812.558.914.654.746.12
90.0091.5293.5993.4292.0692.4793.6093.6993.5993.2992.2191.7292.0591.9592.0592.3392.1392.5392.0791.93----
0.140.260.480.570.720.790.860.951.041.272.052.362.742.883.073.343.483.834.094.590000
222949585856698080102188185242286307358286383334315273374437427
13.7510.259.519.547.436.597.487.887.227.528.467.198.129.149.219.917.589.267.536.315.026.577.336.75
62919231815242123286158131163123114399122-105-95-14540
-383.33-34.4821.05-21.74-16.6760.00-12.509.5221.74117.86-4.92125.8624.43-24.54-7.32-65.79133.33-75.82-577.27-9.52-85.26-485.71-
------------------------
------------------------
30.630.630.631.233.534.435.235.537.337.3868686.590.795.296.3105.8105.3120.5170.590000
------------------------
Details

Keystats

Revenue and Growth

The Clariane Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Clariane is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (B)GOODWILL (B)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (B)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
20042005200620072008200920102011201220132014201520162017201820192020202120222023
                                       
0.020.080.050.140.140.170.140.150.160.050.240.520.310.510.550.351.161.220.740.68
12424075818786928086143154168191236284315365440565.17
8212000000110120198170196212152182309416353576.04
0123333334781010173436282928.3
35407107117143228285425860101231127.94
0.040.150.120.220.230.270.240.260.360.280.620.880.710.9310.91.882.131.791.98
0.20.160.20.280.260.30.340.410.390.561.171.31.671.942.295.476.16.5576.8
7111515131318192026333133545738706270167.77
00000000000000000000
0.20.490.50.530.590.590.620.680.660.661.711.71.721.761.821.942.162.182.262.34
0.10.360.410.630.610.620.640.690.670.741.621.712.182.222.312.52.913.213.243.29
4441827263338136591081491842091407679176217608.88
0.51.031.131.461.51.551.661.831.872.044.644.885.786.196.6210.0411.3212.1812.7913.2
0.551.171.251.681.731.821.92.092.232.325.255.766.497.127.6210.9413.214.3114.5815.18
                                       
153254138138138157161164170174395397401405410414525528533534.14
00.110.230.230.220.260.270.280.290.290.920.930.840.860.880.91.181.21.211.21
00.040.260.270.270.270.270.260.30.280.590.60.781.21.271.241.451.771.81.84
00000000-4000000000000
00000000000000000000
0.160.40.630.640.630.690.70.70.710.751.91.922.022.462.562.563.163.493.543.58
11242354798893114124133239228250267315370454609733753.68
00000000581552672863390305386404406453524.02
3310078110140216249271295221392353382665491621616350318417.65
6121020939107567916788120110.56
0.040.030.030.030.030.040.050.080.050.040.060.080.160.350.270.551.131.041.321.41
0.090.160.140.220.260.390.40.470.540.560.960.951.141.291.391.932.622.412.823.12
0.210.420.290.60.590.510.530.620.670.711.622.072.162.52.865.726.487.196.937.08
88164177189203205221246238242638691673633583535605584604546.93
5111329312124315838131119478225220183174366348496.08
0.30.590.480.820.830.740.780.90.960.992.392.883.313.363.666.447.268.147.888.12
0.390.760.621.041.091.121.181.371.51.553.353.834.464.645.068.379.8810.5410.7111.24
0.551.151.251.671.711.811.882.072.212.295.265.756.487.17.6110.9313.0314.0414.2514.83
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of Clariane provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Clariane's financial health and stability.

Assets

Clariane's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Clariane must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Clariane after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Clariane's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
20042005200620072008200920102011201220132014201520162017201820192020202120222023
630222721182725253164611331661251164212145-80
914161628243131485797146160176142460524612617750
0-670-60-1-1-1-551-72-72-800000
-2231-251120181435-149-2192116117-62-53-142-52-107
20-8-6-82263718496958-500251281248251241
00000000314376519796102179194190180140
0000000000000005966448740
-470114855648598126118247245307385377765794840861804
-2-32-55-63-106-78-97-79-73-121-112-140-159-188-264-326-520-528-622-484
-7-328-71-292-2037-91-107-30-64-131-193-508-331-363-636-1,097-825-770-669
-5-296-16-228851165-284256-18-53-349-142-98-310-577-296-148-185
00000000000000000000
-986-125287-6-152194564-114173319111-13159-124655-31-307-288
392041560067108-101000016399229334
0.030.290.030.28-0.02-0.1-0.0200.03-0.170.070.23-0.010.160.02-0.331.110.03-0.55-0.19
000000-27-31-31-43-76-54-97199-110-187-1836-214-173
000-9-14-16-18-19-4-7-29-34-28-30-24-240-36-57-65
1732-2934131-22-7122-111183281-21520938-20581050-464-57
-738.2-43.8-15.1-50.9-13.9-12.119.553.3-2.7134.2105147.8196.5112.7439.4274.8311.1239.4320.04
00000000000000000000

Clariane stock margins

The Clariane margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Clariane. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Clariane.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Clariane's sales revenue. A higher gross margin percentage indicates that the Clariane retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Clariane's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Clariane's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Clariane's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Clariane. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Clariane's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Clariane Margin History

Clariane Gross marginClariane Profit marginClariane EBIT marginClariane Profit margin
2027e91.93 %6.76 %0 %
2026e91.93 %7.34 %0.92 %
2025e91.93 %6.59 %-0.26 %
2024e91.93 %5.04 %-1.76 %
202391.93 %6.31 %-2.11 %
202292.07 %7.53 %0.5 %
202192.52 %9.27 %2.2 %
202092.13 %7.58 %1.04 %
201992.34 %9.92 %3.18 %
201892.05 %9.23 %3.69 %
201791.93 %9.16 %5.22 %
201692.07 %8.13 %4.4 %
201591.75 %7.21 %2.28 %
201492.22 %8.47 %2.76 %
201393.31 %7.53 %2.11 %
201293.62 %7.26 %2.1 %
201193.69 %7.91 %2.14 %
201093.56 %7.48 %2.68 %
200992.48 %6.68 %1.76 %
200892.12 %7.45 %2.3 %
200793.51 %9.66 %3.8 %
200693.51 %9.52 %3.82 %
200591.53 %10.42 %10.42 %
200490.27 %13.9 %3.99 %

Clariane Stock Sales Revenue, EBIT, Earnings per Share

The Clariane earnings per share therefore indicates how much revenue Clariane has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Clariane earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Clariane's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Clariane’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Clariane's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Clariane Revenue, EBIT and net profit per share

DateClariane Sales per ShareClariane EBIT per shareClariane Earnings per Share
2027e17.79 undefined0 undefined0 undefined
2026e16.76 undefined0 undefined0.15 undefined
2025e16 undefined0 undefined-0.04 undefined
2024e15.29 undefined0 undefined-0.27 undefined
202329.28 undefined1.85 undefined-0.62 undefined
202236.83 undefined2.78 undefined0.18 undefined
202139.29 undefined3.64 undefined0.87 undefined
202035.66 undefined2.7 undefined0.37 undefined
201937.51 undefined3.72 undefined1.19 undefined
201835.02 undefined3.23 undefined1.29 undefined
201734.52 undefined3.16 undefined1.8 undefined
201634.47 undefined2.8 undefined1.52 undefined
201529.92 undefined2.16 undefined0.68 undefined
201425.84 undefined2.19 undefined0.71 undefined
201336.36 undefined2.74 undefined0.77 undefined
201229.72 undefined2.16 undefined0.62 undefined
201128.59 undefined2.26 undefined0.61 undefined
201026.22 undefined1.96 undefined0.7 undefined
200924.73 undefined1.65 undefined0.44 undefined
200823.32 undefined1.74 undefined0.54 undefined
200719.5 undefined1.88 undefined0.74 undefined
200616.86 undefined1.6 undefined0.64 undefined
20059.25 undefined0.96 undefined0.96 undefined
20045.24 undefined0.73 undefined0.21 undefined

Clariane business model

Korian SA is a leading European provider of care and support services for elderly and dependent people. The company was founded in France in 2003 and operates over 810 facilities in eight countries, including France, Germany, Italy, Spain, Belgium, and the Netherlands. The company's business model is focused on providing appropriate solutions for every needy elderly person in any situation. Korian is divided into four main segments: long-term care, short-term care, assisted living, and psychiatric care. The company values the quality of care and support to ensure the highest possible standard of living for the individuals and their families. Korian offers a wide range of products and services, including care, support, catering, medical services, and targeted training for physical and mental fitness. The company develops innovative technologies to improve residents' living comfort and increase the efficiency of support services. Another important feature of Korian is its commitment to sustainability and corporate social responsibility, including environmentally friendly practices and protecting natural resources. Korian also strives to provide high-quality care and support tailored to the individual needs of older and dependent people. Long-term care is an important area of focus for Korian, as it caters to elderly people with various needs, including those with dementia, Alzheimer's, Parkinson's, or other illnesses. Korian ensures that these individuals have a comfortable and clinically appropriate environment to meet their needs. Short-term care is temporary support for the care needs of mostly younger people after surgeries or injuries. Korian offers a variety of options for short-term care to expedite the recovery process and promote independence. The assisted living segment offers older people the opportunity to live in a communal facility. Korian provides apartments with specific features such as private bathrooms or spacious kitchens. The communal facility offers comprehensive care and support with meals, laundry services, doctor visits, and social activities. Psychiatric care is another important sector in which Korian operates. This type of care is intended for people with mental health problems and includes support for those suffering from depression, anxiety, autism, or schizophrenia. Korian offers specialized psychiatric services such as outpatient therapies or inpatient treatments. In summary, Korian SA is a leading European provider of care and support services for elderly and dependent people. The company offers a wide range of products and services to ensure the highest possible standard of living for the individuals and their families. Korian strives to provide high-quality care and support tailored to the individual needs of each person. Clariane is one of the most popular companies on Eulerpool.com.

Clariane SWOT Analysis

Strengths

  • Established brand presence in the global market.
  • Diverse product portfolio, including skincare, cosmetics, and fragrances.
  • Strong research and development capabilities, leading to innovative and high-quality products.

Weaknesses

  • Relatively higher prices compared to some competitors.
  • Overreliance on Asian market, limiting potential growth in other regions.
  • Lack of focus on sustainable and environmentally-friendly practices, which may pose risks in the long run.

Opportunities

  • Increasing demand for natural and organic beauty products, providing a chance for Korian SA to expand its offerings.
  • Growing e-commerce industry, enabling Korian SA to reach a wider customer base through online channels.
  • Potential for strategic partnerships or acquisitions to enhance market presence and diversify product range.

Threats

  • Intense competition from both established and emerging beauty brands.
  • Economic fluctuations and geopolitical issues, which may impact consumer purchasing power and demand for luxury beauty products.
  • Increasing regulations and consumer preferences towards cruelty-free and environmentally-friendly products, requiring adaptation of practices.

Clariane Eulerpool Fair Value

Details

Fair Value

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Clariane historical P/E ratio, EBIT multiple, and P/S ratio

Clariane shares outstanding

The number of shares was Clariane in 2023 — This indicates how many shares 170.587 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Clariane earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Clariane's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Clariane’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Clariane's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Clariane dividend history and estimates

In 2023, Clariane paid a dividend amounting to 0.25 EUR. Dividend means that Clariane distributes a portion of its profits to its owners.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

Dividend Overview

The dividend per year chart for Clariane provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Clariane’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Clariane's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Clariane Dividend History

DateClariane Dividend
2027e0.25 undefined
2026e0.25 undefined
2025e0.25 undefined
2024e0.25 undefined
20230.25 undefined
20220.35 undefined
20210.3 undefined
20190.55 undefined
20180.55 undefined
20170.55 undefined
20160.55 undefined
20150.55 undefined
20140.28 undefined
20130.55 undefined
20120.55 undefined
20110.55 undefined
20100.55 undefined
20090.55 undefined
20080.5 undefined
20070.32 undefined

Clariane dividend payout ratio

In 2023, Clariane had a payout ratio of 107.1%. The payout ratio indicates the percentage of the company's profits that Clariane distributes as dividends.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

What is Yearly Payout Ratio?

The yearly payout ratio for Clariane represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Clariane could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Clariane's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Clariane Payout Ratio History

DateClariane Payout ratio
2027e123.03 %
2026e119.05 %
2025e137.89 %
2024e112.14 %
2023107.1 %
2022194.44 %
202134.88 %
202091.97 %
201946.57 %
201842.96 %
201730.79 %
201636.46 %
201581.5 %
201439.03 %
201371.97 %
201289.39 %
201187.97 %
201079.17 %
2009128.88 %
200894.11 %
200743.69 %
200691.97 %
200591.97 %
200491.97 %
Unfortunately, there are currently no price targets and forecasts available for Clariane.

Clariane latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
12/31/20160.4 1.14  (185.69 %)2016 Q4
1

Eulerpool ESG Scorecard© for the Clariane stock

Eulerpool World ESG Rating (EESG©)

93/ 100

🌱 Environment

99

👫 Social

99

🏛️ Governance

80

Environment

Scope 1 - Direct Emissions
74,844
Scope 2 - Indirect emissions from purchased energy
50,721
Scope 3 - Indirect emissions within the value chain
314,145
Total CO₂ emissions
142,738.085
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees81
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Clariane shareholders

%
Name
Stocks
Change
Date
7.40826 % Crédit Agricole Assurances S.A.26,358,07306/19/2023
2.26206 % Malakoff Médéric8,048,26006/19/2023
1.92246 % PSP Investments6,839,99606/19/2023
1.50228 % Holecek (M. Rene)5,345,0005,345,0003/22/2024
0.47064 % Dimensional Fund Advisors, L.P.1,674,49003/31/2024
0.30977 % Charles Schwab Investment Management, Inc.1,102,124293,4083/31/2024
0.09549 % Florida State Board of Administration339,75786,5819/30/2022
0.04901 % Sycomore Asset Management174,37901/31/2024
0.04789 % Allspring Global Investments, LLC170,404-60,9862/29/2024
0.03862 % Erste Asset Management GmbH137,424-68,7121/31/2024
1
2
3
4
5
...
10

Clariane Executives and Management Board

Mrs. Sophie Boissard52
Clariane Chief Executive Officer, Member of the Executive Committee, Director (since 2016)
Compensation 1.01 M
Mr. Jean-Pierre Duprieu72
Clariane Independent Chairman of the Board of Directors
Compensation 345,000
Ms. Catherine Soubie57
Clariane Independent Director
Compensation 65,384
Mrs. Anne Lalou59
Clariane Independent Director
Compensation 55,472
Dr. Jean-Francois Brin59
Clariane Independent Director
Compensation 39,537
1
2
3
4
5
...
6

Most common questions regarding Clariane

What values and corporate philosophy does Clariane represent?

Korian SA represents values of compassion, expertise, and innovation in the healthcare industry. As a leading company in Europe, Korian is committed to providing quality care and support to seniors and persons with disabilities. With a strong corporate philosophy of person-centered care, Korian focuses on promoting autonomy, well-being, and social integration for its residents. Through continuous research and development, they strive to deliver innovative solutions and services that meet the evolving needs of their customers. Korian SA's dedication to these values and corporate philosophy has established them as a trusted and respected healthcare provider in the market.

In which countries and regions is Clariane primarily present?

Korian SA is primarily present in several countries and regions. These include France, Germany, Italy, Belgium, Spain, and the Netherlands. With its strong presence in these countries, Korian SA has established itself as a leading healthcare group specializing in elderly care services. The company's extensive network and expertise in managing nursing homes, post-acute care, and assisted living facilities have made it a trusted name in the industry.

What significant milestones has the company Clariane achieved?

Korian SA, a prominent company in the healthcare sector, has achieved several significant milestones. Over the years, Korian has successfully established itself as a leader in Europe's elderly care and support services. The company has experienced substantial growth, expanding its presence through strategic acquisitions and partnerships across multiple countries. Korian's commitment to providing high-quality care and innovative solutions has been recognized through numerous awards and accolades. With its strong operational performance and focus on patient-driven care, Korian SA continues to make significant strides in improving the lives of seniors and enhancing the overall healthcare industry.

What is the history and background of the company Clariane?

Korian SA, a leading European care services company, has an extensive history and background. Established in 2003, Korian has rapidly expanded to become a trusted provider of elderly and healthcare services. With a presence in France, Germany, Belgium, Italy, the Netherlands, and Spain, Korian offers a wide range of care solutions, including nursing homes, assisted living facilities, and home care services. The company focuses on maintaining residents' well-being and quality of life through its personalized approach and commitment to professional and compassionate care. Korian SA continually strives to innovate and improve its services to meet the ever-evolving needs of its customers.

Who are the main competitors of Clariane in the market?

The main competitors of Korian SA in the market are Orpea SA and Colisée Group.

In which industries is Clariane primarily active?

Korian SA is primarily active in the healthcare industry, specifically in the field of elderly care and support services. As one of the leading European providers, Korian specializes in offering a range of services such as residential care, nursing homes, and assisted living facilities. With a focus on enhancing the quality of life for seniors, Korian SA aims to provide comprehensive and personalized care solutions. This holistic approach allows the company to cater to the evolving needs of the aging population and maintain its prominent position in the healthcare sector.

What is the business model of Clariane?

Korian SA is a leading European company specializing in the senior care sector. The company's business model revolves around providing high-quality and personalized care services to the aging population. Korian SA operates a wide range of facilities including nursing homes, assisted living residences, and home care services. By focusing on professional and compassionate care, Korian SA aims to enhance the well-being and autonomy of seniors while meeting their specific needs. With a strong commitment to innovation and expertise, Korian SA continues to play a pivotal role in shaping the future of the senior care industry.

What is the P/E ratio of Clariane 2024?

The Clariane P/E ratio is -2.86.

What is the P/S ratio of Clariane 2024?

The Clariane P/S ratio is 0.05.

What is the Quality Investing of Clariane?

The Quality Investing for Clariane is 5/10.

What is the revenue of Clariane 2024?

The expected Clariane revenue is 5.44 B EUR.

How high is the profit of Clariane 2024?

The expected Clariane profit is -95.85 M EUR.

What is the business model of Clariane

Korian SA is a French company specializing in providing care and support services for older people, people with disabilities, and people with mental illnesses. The company was founded in 2003 and is headquartered in Paris. It is currently the largest provider of nursing homes in Europe, operating around 850 care facilities in France, Germany, Belgium, Italy, Spain, and the Netherlands. Korian's business model focuses on offering high-quality, tailored care and support services to meet the individual needs of each customer. Their goal is to ensure high-quality care while promoting the independence and autonomy of their customers. The Korian group offers a wide range of different care and support services to meet the diverse needs of their customers. Their products include residential care facilities, day and night centers, home care, socio-educational facilities, and care facilities for people with mental illnesses. The company relies on advanced technology and innovative care concepts to guarantee the highest quality of services. Korian is divided into three main business areas: Korian France, Korian Germany, and Korian International. Korian France is the largest business area, operating around 300 care facilities in France. Korian Germany is the second-largest business area, operating around 250 care facilities in Germany. Korian International is the smallest business area, operating around 300 care facilities in Europe. Korian adopts a decentralized management structure that allows each business area to operate independently and respond to the needs of local markets. The company is known for its continuous investments in innovation and research, with the aim of providing customers with the latest technology in care and support. Another important aspect of Korian's business model is close cooperation with local communities and the public to create a safe and pleasant environment. The company also supports social and ecological sustainability criteria and promotes the integration of people with disabilities and older people into society. Overall, Korian's business model is focused on providing high-quality care and support. The company offers a wide range of products and services tailored to the individual needs of its customers, while placing social and ecological sustainability, innovation, and research at the forefront.

What is the Clariane dividend?

Clariane pays a dividend of 0.35 EUR distributed over 1 payouts per year.

How often does Clariane pay dividends?

Clariane pays out a dividend 1 times a year.

What is the Clariane ISIN?

The ISIN of Clariane is FR0010386334.

What is the Clariane WKN?

The WKN of Clariane is A0LE05.

What is the Clariane ticker?

The ticker of Clariane is CLARI.PA.

How much dividend does Clariane pay?

Over the past 12 months, Clariane paid a dividend of 0.25 EUR . This corresponds to a dividend yield of about 15.54 %. For the coming 12 months, Clariane is expected to pay a dividend of 0.25 EUR.

What is the dividend yield of Clariane?

The current dividend yield of Clariane is 15.54 %.

When does Clariane pay dividends?

Clariane pays a quarterly dividend. This is distributed in the months of July, July, July, July.

How secure is the dividend of Clariane?

Clariane paid dividends every year for the past 0 years.

What is the dividend of Clariane?

For the upcoming 12 months, dividends amounting to 0.25 EUR are expected. This corresponds to a dividend yield of 15.5 %.

In which sector is Clariane located?

Clariane is assigned to the 'Health' sector.

Wann musste ich die Aktien von Clariane kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Clariane from 7/13/2023 amounting to 0.25 EUR, you needed to have the stock in your portfolio before the ex-date on 6/21/2023.

When did Clariane pay the last dividend?

The last dividend was paid out on 7/13/2023.

What was the dividend of Clariane in the year 2023?

In the year 2023, Clariane distributed 0.35 EUR as dividends.

In which currency does Clariane pay out the dividend?

The dividends of Clariane are distributed in EUR.

All fundamentals about Clariane

Our stock analysis for Clariane Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Clariane Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.